Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Educator, Historian and UNC Statistician Freddie Kiger Inducted Into Order of Longleaf Pine
A Chapel Hill institution and longtime community contributor was recent recognized with the highest civilian honor in North Carolina. Members of the East Chapel Hill...
Sat Jan 10, 2026

90-year-old Triad neurosurgeon ‘finally’ earns UNC undergraduate degree
Dr. David L. Kelly Jr. says this moment is a dream come true. “I’m finally getting my undergraduate degree because I lacked one course by...
Tue Jan 6, 2026

UNC School of Pharmacy retains No. 1 ranking for external research funding
The UNC Eshelman School of Pharmacy has retained its No. 1 American Association of Colleges of Pharmacy ranking for external research funding among U.S. schools...
Mon Jan 5, 2026

A Victory of ‘Time and Patience’: Live and Local with Tift Merritt
Local music legend Tift Merritt stopped by Live & Local, following the release of a pair of albums: the 20th-anniversary re-release of her Grammy-nominated sophomore...
Sun Jan 4, 2026